132 related articles for article (PubMed ID: 38287527)
1. Skeletal muscle index impacts the treatment outcome of elderly patients with diffuse large B cell lymphoma.
Niiyama-Uchibori Y; Okamoto H; Miyashita A; Mizuhara K; Kanayama-Kawaji Y; Fujino T; Tsukamoto T; Mizutani S; Shimura Y; Teramukai S; Kuroda J
Hematol Oncol; 2024 Jan; 42(1):e3252. PubMed ID: 38287527
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of sarcopenia in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
Go SI; Park MJ; Song HN; Kim HG; Kang MH; Lee HR; Kim Y; Kim RB; Lee SI; Lee GW
J Cachexia Sarcopenia Muscle; 2016 Dec; 7(5):567-576. PubMed ID: 27104110
[TBL] [Abstract][Full Text] [Related]
3. Skeletal muscle density is an independent predictor of diffuse large B-cell lymphoma outcomes treated with rituximab-based chemoimmunotherapy.
Chu MP; Lieffers J; Ghosh S; Belch A; Chua NS; Fontaine A; Sangha R; Turner RA; Baracos VE; Sawyer MB
J Cachexia Sarcopenia Muscle; 2017 Apr; 8(2):298-304. PubMed ID: 27897411
[TBL] [Abstract][Full Text] [Related]
4. Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy.
Lanic H; Kraut-Tauzia J; Modzelewski R; Clatot F; Mareschal S; Picquenot JM; Stamatoullas A; Leprêtre S; Tilly H; Jardin F
Leuk Lymphoma; 2014 Apr; 55(4):817-23. PubMed ID: 23781925
[TBL] [Abstract][Full Text] [Related]
5. Sarcopenia is an independent prognostic factor in male patients with diffuse large B-cell lymphoma.
Nakamura N; Hara T; Shibata Y; Matsumoto T; Nakamura H; Ninomiya S; Kito Y; Kitagawa J; Kanemura N; Goto N; Shiraki M; Miyazaki T; Takeuchi T; Shimizu M; Tsurumi H
Ann Hematol; 2015 Dec; 94(12):2043-53. PubMed ID: 26385388
[TBL] [Abstract][Full Text] [Related]
6. Clinical and prognostic role of sarcopenia in elderly patients with classical Hodgkin lymphoma: a multicentre experience.
Zilioli VR; Albano D; Arcari A; Merli F; Coppola A; Besutti G; Marcheselli L; Gramegna D; Muzi C; Manicone M; Camalori M; Ciammella P; Colloca G; Tucci A
J Cachexia Sarcopenia Muscle; 2021 Aug; 12(4):1042-1055. PubMed ID: 34114749
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of fat tissue loss and cachexia assessed by computed tomography scan in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy.
Camus V; Lanic H; Kraut J; Modzelewski R; Clatot F; Picquenot JM; Contentin N; Lenain P; Groza L; Lemasle E; Fronville C; Cardinael N; Fontoura ML; Chamseddine A; Brehar O; Stamatoullas A; Leprêtre S; Tilly H; Jardin F
Eur J Haematol; 2014 Jul; 93(1):9-18. PubMed ID: 24520908
[TBL] [Abstract][Full Text] [Related]
8. Combination of Sarcopenia and Anemia Predicts Worse Outcome in Elderly Patients With Diffuse Large B-Cell Lymphoma.
Liao PH; Chuang YH; Yang FS; Kuo CY; Ma MC; Liao CK; Wang MC
In Vivo; 2023; 37(4):1847-1856. PubMed ID: 37369473
[TBL] [Abstract][Full Text] [Related]
9. Prognostic model based on the geriatric nutritional risk index and sarcopenia in patients with diffuse large B-cell lymphoma.
Go SI; Kim HG; Kang MH; Park S; Lee GW
BMC Cancer; 2020 May; 20(1):439. PubMed ID: 32423395
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of prognostic nutritional index in diffuse large B cell lymphoma.
Go SI; Park S; Kang MH; Kim HG; Kim HR; Lee GW
Ann Hematol; 2019 Feb; 98(2):401-411. PubMed ID: 30413902
[TBL] [Abstract][Full Text] [Related]
11. Implications of Sarcopenia and Glucometabolism Parameters of Muscle Derived From Baseline and End-of-Treatment
Tan X; Sun X; Chen Y; Wang F; Shang Y; Zhang Q; Yuan H; Jiang L
Korean J Radiol; 2024 Mar; 25(3):277-288. PubMed ID: 38413112
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of the psoas muscle index, a parameter of sarcopenia, in patients with diffuse large B-cell lymphoma treated with rituximab-based chemoimmunotherapy.
Iltar U; Sözel H; Sözel YK; Ataş Ü; Yücel OK; Salim O; Aydin F; Undar L
Leuk Lymphoma; 2021 May; 62(5):1098-1106. PubMed ID: 33300380
[TBL] [Abstract][Full Text] [Related]
13. [Low psoas muscle index as independent poor prognostic factor for diffuse large B-cell lymphoma in elderly patients].
Arai K; Mitsuhashi K; Honjo Y; Kurachi M; Komiya Y; Arao T; Sato H
Rinsho Ketsueki; 2022; 63(1):7-13. PubMed ID: 35135956
[TBL] [Abstract][Full Text] [Related]
14. Visceral adipose tissue is prognostic for survival of diffuse large B cell lymphoma treated with frontline R-CHOP.
Shin DY; Kim A; Byun BH; Moon H; Kim S; Ko YJ; Kim MJ; Lee HR; Kang HJ; Na II; Park S; Lee SS; Yang SH
Ann Hematol; 2016 Feb; 95(3):409-16. PubMed ID: 26658607
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of different staging systems and prognostic analysis of 110 primary gastrointestinal diffuse large B cell lymphoma].
Mao L; Wang X; Wang CY; Xia B; Ning QY; Yang HL; Yu Y; Zhang YZ
Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(24):1853-1858. PubMed ID: 31269579
[No Abstract] [Full Text] [Related]
16. [Comparison the efficacy and prognosis of different first-line treatment for elderly diffuse large B-cell lymphoma].
Liu P; Jiang SY; He XH; Qin Y; Gui L; Zhou SY; Yang JL; Yang S; Wen TY; Shi YK
Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):234-241. PubMed ID: 32252203
[No Abstract] [Full Text] [Related]
17. Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study.
Kim IH; Choi MH; Lee IS; Hong TH; Lee MA
BMC Cancer; 2021 Jan; 21(1):77. PubMed ID: 33461517
[TBL] [Abstract][Full Text] [Related]
18. Cachexia index as a potential biomarker for cancer cachexia and a prognostic indicator in diffuse large B-cell lymphoma.
Go SI; Park MJ; Park S; Kang MH; Kim HG; Kang JH; Kim JH; Lee GW
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):2211-2219. PubMed ID: 34676685
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal Body Composition Changes in Diffuse Large B-cell Lymphoma Survivors: A Retrospective Cohort Study of United States Veterans.
Xiao DY; Luo S; O'Brian K; Sanfilippo KM; Ganti A; Riedell P; Lynch RC; Liu W; Kahl BS; Cashen AF; Fehniger TA; Carson KR
J Natl Cancer Inst; 2016 Nov; 108(11):. PubMed ID: 27381623
[TBL] [Abstract][Full Text] [Related]
20. Role of virological serum markers in patients with both hepatitis B virus infection and diffuse large B-cell lymphoma.
Zhou X; Wuchter P; Egerer G; Kriegsmann M; Mataityte A; Koelsche C; Witzens-Harig M; Kriegsmann K
Eur J Haematol; 2019 Oct; 103(4):410-416. PubMed ID: 31338887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
